Target intelligence / Profile preview

Kinesin-like protein KIF3A (KIF3A)

Target
KIF3A
Molecular classification
Motor protein, Microtubule-associated protein, Kinesin superfamily protein (kinesin-2 subfamily), Cytoskeletal protein
01

Overview

Kinesin-like protein KIF3A is a component of the kinesin-2 complex—a microtubule plus end-directed motor protein complex responsible for the anterograde transport of vesicles, protein complexes, and organelles along microtubules[1][2]. KIF3A, functioning as a heterotrimer with KIF3B or KIF3C and the associated protein KAP3, is essential for the formation and maintenance of cilia and flagella, regulates crucial signaling pathways (notably Wnt/β-catenin), and plays a prominent role in the development, differentiation, and homeostasis of a wide array of tissues[1][2][3][5]. Mutations or dysregulation of KIF3A are implicated in the pathogenesis of polycystic kidney disease, multiple solid tumor types, organ fibrosis, and developmental anomalies, making it a key candidate for research in ciliopathies and cancer biology[2][3][5]. Direct therapeutic targeting is not currently established, but its biological significance is well recognized.

Other names
KIF3AKinesin family member 3AKinesin-like protein KIF3AKIF3FLA10KLP-20Microtubule plus end-directed kinesin motor 3Akinesin family protein 3A
02

Biological functions

Anterograde transport along microtubulesCiliogenesis (formation and maintenance of cilia and flagella)Signal transduction (cilia-based signaling)Embryonic development (establishment of left-right asymmetry)Cell movement (e.g., clearance of lung mucus, cerebrospinal fluid flow)Vesicle and organelle transportRegulation of cell proliferation and apoptosis (via Wnt/β-catenin signaling pathway)
03

Disease associations

Polycystic kidney diseaseCancer (e.g., non-small cell lung cancer, thyroid cancer, prostate cancer, triple-negative breast cancer, nasopharyngeal carcinoma)Organ fibrosisInflammatory diseases (including asthma)Developmental disorders
04

Safety considerations

Potential for disrupting essential ciliary function if KIF3A is inhibited (leading to ciliary defects and diseases such as polycystic kidney disease[2][3])Broad involvement in key developmental and homeostatic pathways (risk of unintended systemic effects)
05

Biomarkers

KIF3A expression (prognostic marker in cancers such as non-small cell lung cancer[5])KIF3A gene alterations (potential diagnostic or prognostic value in ciliopathies and certain cancers[3][5])

Beyond the preview

Go deeper on Kinesin-like protein KIF3A (KIF3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin-like protein KIF3A (KIF3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call